Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

de Heer, E C; Zois, C E; Bridges, E; van der Vegt, B; Sheldon, H; Veldman, W A; Zwager, M C; van der Sluis, T; Haider, S; Morita, T; Baba, O; Schröder, C P; de Jong, S; Harris, A L; Jalving, M

de Heer, E C; Zois, C E; Bridges, E; van der Vegt, B; Sheldon, H; Veldman, W A; Zwager, M C; van der Sluis, T; Haider, S; Morita, T; Baba, O; Schröder, C P; de Jong, S; Harris, A L; Jalving, M.

Afiliação

de Heer EC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands.
Zois CE; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk.
Bridges E; Department of Radiotherapy and Oncology, School of Health, Democritus University of Thrace, Alexandroupolis, Greece. christos.zois@oncology.ox.ac.uk.
van der Vegt B; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, Molecular Oncology Laboratories, John Radclife Hospital, Oxford University, Oxford, OX3 9DS, UK. christos.zois@oncology.ox.ac.uk.
Sheldon H; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK.
Veldman WA; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Zwager MC; Department of Oncology, Weatherall Institute of Molecular Medicine, Hypoxia and Angiogenesis Group, Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Oxford, OX3 9DS, UK.
van der Sluis T; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands.
Haider S; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Morita T; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Baba O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Schröder CP; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan.
de Jong S; Tokushima University Graduate School, 3-18-15, Kuramoto-Cho, Tokushima, 770-8504, Japan.
Harris AL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, Groningen, 9700 RB, The Netherlands.
Jalving M; Department of Medical Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.

J Exp Clin Cancer Res ; 42(1): 220, 2023 Aug 28.

Article em En | MEDLINE | ID: mdl-37635223

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google